2nd Quarter - Report
THE KPM GROUP DC LLC for RARE DISEASE COMPANY COALITION
Firm
Income
$130,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FRISK | — |
| JACOB JACKSON | — |
| PATROSKI LAWSON | — |
| YOKO ROSENBAUM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.